Bayesian Capital Management, LP Pet Iq, Inc. Transaction History

Bayesian Capital Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$6.82 - $12.07 $83,538 - $147,845	12,249 New	12,249 $112,000
Q1 2019 May 14, 2019	SELL	$23.31 - $31.41 $493,799 - $665,389	-21,184 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$21.6 - $37.49 $64,800 - $112,470	-3,000 Reduced 12.4%	21,184 $497,000
Q3 2018 Nov 14, 2018	BUY	$25.67 - $42.36 $338,844 - $559,152	13,200 Added 120.17%	24,184 $951,000
Q2 2018 Aug 14, 2018	BUY	$17.91 - $26.86 $196,723 - $295,030	10,984 New	10,984 $295,000

189

30M

81K

113K

Ticker PETQ
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,312,800
Market Cap $908M
Description
PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which include flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medicat...

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Bayesian Capital Management, LP with notifications on news.